NEW YORK (GenomeWeb News) — Agendia yesterday said it has given Argentine distributor Teva & Tutor exclusive rights to market Agendia's MammaPrint microarray in Argentina and Paraguay.
 
Agendia, based in the Netherlands, said that this South American expansion is part of a larger global sales effort, and said this is "an important step in opening more markets."
 
Financial terms of the agreement were not released.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.